Skip to main content
HairCited

描述

In vitro drug release profiles for betamethasone and minoxidil from the PNP and NLC nanoformulations. Sustained release kinetics suggest prolonged drug availability at the hair follicle target site.

Cite This Figure

![Figure 3: In vitro drug release profiles for betamethasone and minoxidil from the PNP and NLC nanoformulations. Sustained release kinetics suggest prolonged drug availability at the hair follicle target site.]()

> Source: Breno N Matos et al. "Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polyme." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37765130](https://pubmed.ncbi.nlm.nih.gov/37765130/)
<figure>
  <img src="" alt="In vitro drug release profiles for betamethasone and minoxidil from the PNP and NLC nanoformulations. Sustained release kinetics suggest prolonged drug availability at the hair follicle target site." />
  <figcaption>Figure 3. In vitro drug release profiles for betamethasone and minoxidil from the PNP and NLC nanoformulations. Sustained release kinetics suggest prolonged drug availability at the hair follicle target site.<br>  Source: Breno N Matos et al. "Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polyme." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37765130/">37765130</a></figcaption>
</figure>